BI 907828

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 907828, covering 2025-01-22 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor [Phase 1]

See pricing